Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:revised fibromyalgia impact questionnaire'
(id=6890178 ; fe=en:revised fibromyalgia impact questionnaire ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=6019 creation date=2017-06-25 touchdate=2024-09-18 19:42:37.000)
≈ 277 relations sortantes

  1. en:revised fibromyalgia impact questionnaire -- r_associated #0: 43 / 1 -> en:hemophilia quality of life questionnaire children's short version age group ii/iii
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire children's short version age group ii/iii | rel=r_associated | relid=0 | w=43
  2. en:revised fibromyalgia impact questionnaire -- r_associated #0: 43 / 1 -> en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire | rel=r_associated | relid=0 | w=43
  3. en:revised fibromyalgia impact questionnaire -- r_associated #0: 42 / 0.977 -> en:multiple sclerosis quality of life-54 instrument questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:multiple sclerosis quality of life-54 instrument questionnaire | rel=r_associated | relid=0 | w=42
  4. en:revised fibromyalgia impact questionnaire -- r_associated #0: 42 / 0.977 -> en:sf-12
    n1=en:revised fibromyalgia impact questionnaire | n2=en:sf-12 | rel=r_associated | relid=0 | w=42
  5. en:revised fibromyalgia impact questionnaire -- r_associated #0: 42 / 0.977 -> en:shortness of breath with daily activities questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:shortness of breath with daily activities questionnaire | rel=r_associated | relid=0 | w=42
  6. en:revised fibromyalgia impact questionnaire -- r_associated #0: 41 / 0.953 -> en:breast cancer prevention trial symptom scales
    n1=en:revised fibromyalgia impact questionnaire | n2=en:breast cancer prevention trial symptom scales | rel=r_associated | relid=0 | w=41
  7. en:revised fibromyalgia impact questionnaire -- r_associated #0: 41 / 0.953 -> en:european organization for research and treatment of cancer quality of life questionnaire core 30
    n1=en:revised fibromyalgia impact questionnaire | n2=en:european organization for research and treatment of cancer quality of life questionnaire core 30 | rel=r_associated | relid=0 | w=41
  8. en:revised fibromyalgia impact questionnaire -- r_associated #0: 40 / 0.93 -> en:asthma control questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:asthma control questionnaire | rel=r_associated | relid=0 | w=40
  9. en:revised fibromyalgia impact questionnaire -- r_associated #0: 40 / 0.93 -> en:sheehan disability scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:sheehan disability scale questionnaire | rel=r_associated | relid=0 | w=40
  10. en:revised fibromyalgia impact questionnaire -- r_associated #0: 40 / 0.93 -> en:standards pain relief questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:standards pain relief questionnaire | rel=r_associated | relid=0 | w=40
  11. en:revised fibromyalgia impact questionnaire -- r_associated #0: 40 / 0.93 -> en:symptom impact questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:symptom impact questionnaire | rel=r_associated | relid=0 | w=40
  12. en:revised fibromyalgia impact questionnaire -- r_associated #0: 40 / 0.93 -> en:the overactive bladder questionnaire short form
    n1=en:revised fibromyalgia impact questionnaire | n2=en:the overactive bladder questionnaire short form | rel=r_associated | relid=0 | w=40
  13. en:revised fibromyalgia impact questionnaire -- r_associated #0: 39 / 0.907 -> en:current opioid misuse measure questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:current opioid misuse measure questionnaire | rel=r_associated | relid=0 | w=39
  14. en:revised fibromyalgia impact questionnaire -- r_associated #0: 39 / 0.907 -> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=39
  15. en:revised fibromyalgia impact questionnaire -- r_associated #0: 39 / 0.907 -> en:patient reported outcomes version of ctcae
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient reported outcomes version of ctcae | rel=r_associated | relid=0 | w=39
  16. en:revised fibromyalgia impact questionnaire -- r_associated #0: 37 / 0.86 -> en:assessment of survivor concerns
    n1=en:revised fibromyalgia impact questionnaire | n2=en:assessment of survivor concerns | rel=r_associated | relid=0 | w=37
  17. en:revised fibromyalgia impact questionnaire -- r_associated #0: 37 / 0.86 -> en:medical outcomes study social activities
    n1=en:revised fibromyalgia impact questionnaire | n2=en:medical outcomes study social activities | rel=r_associated | relid=0 | w=37
  18. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:alcohol use disorder identification test alcohol consumption questions questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alcohol use disorder identification test alcohol consumption questions questionnaire | rel=r_associated | relid=0 | w=36
  19. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:alzheimer's disease cooperative study activities of daily living inventory questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alzheimer's disease cooperative study activities of daily living inventory questionnaire | rel=r_associated | relid=0 | w=36
  20. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:columbia-suicide severity rating scale lifetime/recent version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale lifetime/recent version questionnaire | rel=r_associated | relid=0 | w=36
  21. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:contemplation ladder for smoking cessation
    n1=en:revised fibromyalgia impact questionnaire | n2=en:contemplation ladder for smoking cessation | rel=r_associated | relid=0 | w=36
  22. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:older americans resource scale multidimensional functional assessment questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:older americans resource scale multidimensional functional assessment questionnaire | rel=r_associated | relid=0 | w=36
  23. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:raven's progressive matrices
    n1=en:revised fibromyalgia impact questionnaire | n2=en:raven's progressive matrices | rel=r_associated | relid=0 | w=36
  24. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:rivermead post-concussion symptoms questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:rivermead post-concussion symptoms questionnaire | rel=r_associated | relid=0 | w=36
  25. en:revised fibromyalgia impact questionnaire -- r_associated #0: 36 / 0.837 -> en:short-form mcgill pain questionnaire-2
    n1=en:revised fibromyalgia impact questionnaire | n2=en:short-form mcgill pain questionnaire-2 | rel=r_associated | relid=0 | w=36
  26. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:activities of daily living dimension of functioning questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:activities of daily living dimension of functioning questionnaire | rel=r_associated | relid=0 | w=35
  27. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:alcohol use disorder identification test self-report version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alcohol use disorder identification test self-report version questionnaire | rel=r_associated | relid=0 | w=35
  28. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:asthma quality of life questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:asthma quality of life questionnaire | rel=r_associated | relid=0 | w=35
  29. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:barnes akathisia rating scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:barnes akathisia rating scale questionnaire | rel=r_associated | relid=0 | w=35
  30. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:bladder control scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:bladder control scale questionnaire | rel=r_associated | relid=0 | w=35
  31. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:clinical opiate withdrawal scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:clinical opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=35
  32. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:columbia-suicide severity rating scale since last visit questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale since last visit questionnaire | rel=r_associated | relid=0 | w=35
  33. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:copd assessment test questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:copd assessment test questionnaire | rel=r_associated | relid=0 | w=35
  34. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire | rel=r_associated | relid=0 | w=35
  35. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:fact-hep questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-hep questionnaire | rel=r_associated | relid=0 | w=35
  36. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:fact-np questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-np questionnaire | rel=r_associated | relid=0 | w=35
  37. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:follow-up outcome expectations questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:follow-up outcome expectations questionnaire | rel=r_associated | relid=0 | w=35
  38. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:hemophilia quality of life questionnaire children's long version age group iii
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group iii | rel=r_associated | relid=0 | w=35
  39. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:hemophilia quality of life questionnaire parent's long version age group i
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire parent's long version age group i | rel=r_associated | relid=0 | w=35
  40. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:human activity profile
    n1=en:revised fibromyalgia impact questionnaire | n2=en:human activity profile | rel=r_associated | relid=0 | w=35
  41. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:kaufman assessment battery for children
    n1=en:revised fibromyalgia impact questionnaire | n2=en:kaufman assessment battery for children | rel=r_associated | relid=0 | w=35
  42. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:medical outcomes study physical functioning scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:medical outcomes study physical functioning scale | rel=r_associated | relid=0 | w=35
  43. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:modified medical research council dyspnea scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:modified medical research council dyspnea scale questionnaire | rel=r_associated | relid=0 | w=35
  44. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:multidimensional body-self relations questionnaire appearance orientation
    n1=en:revised fibromyalgia impact questionnaire | n2=en:multidimensional body-self relations questionnaire appearance orientation | rel=r_associated | relid=0 | w=35
  45. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:perceived stress scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:perceived stress scale | rel=r_associated | relid=0 | w=35
  46. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:satisfaction with life scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:satisfaction with life scale questionnaire | rel=r_associated | relid=0 | w=35
  47. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:smoking self-efficacy questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:smoking self-efficacy questionnaire | rel=r_associated | relid=0 | w=35
  48. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:subjective numeracy scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:subjective numeracy scale | rel=r_associated | relid=0 | w=35
  49. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:subjective opiate withdrawal scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:subjective opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=35
  50. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:the overactive bladder questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:the overactive bladder questionnaire | rel=r_associated | relid=0 | w=35
  51. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:treatment satisfaction questionnaire for medication
    n1=en:revised fibromyalgia impact questionnaire | n2=en:treatment satisfaction questionnaire for medication | rel=r_associated | relid=0 | w=35
  52. en:revised fibromyalgia impact questionnaire -- r_associated #0: 35 / 0.814 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire | rel=r_associated | relid=0 | w=35
  53. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:12-item multiple sclerosis walking scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:12-item multiple sclerosis walking scale questionnaire | rel=r_associated | relid=0 | w=34
  54. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:borg scale rating of perceived exertion questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:borg scale rating of perceived exertion questionnaire | rel=r_associated | relid=0 | w=34
  55. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:brief pain inventory questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:brief pain inventory questionnaire | rel=r_associated | relid=0 | w=34
  56. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:clinical copd questionnaire 24 hour version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:clinical copd questionnaire 24 hour version | rel=r_associated | relid=0 | w=34
  57. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:columbia-suicide severity rating scale children's baseline questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale children's baseline questionnaire | rel=r_associated | relid=0 | w=34
  58. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:expanded prostate cancer index composite, sexual medications/devices supplement
    n1=en:revised fibromyalgia impact questionnaire | n2=en:expanded prostate cancer index composite, sexual medications/devices supplement | rel=r_associated | relid=0 | w=34
  59. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:fact-b+4 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-b+4 questionnaire | rel=r_associated | relid=0 | w=34
  60. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:fact-bl questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-bl questionnaire | rel=r_associated | relid=0 | w=34
  61. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:fact-mm questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-mm questionnaire | rel=r_associated | relid=0 | w=34
  62. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:fact-o questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-o questionnaire | rel=r_associated | relid=0 | w=34
  63. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:functional activities questionnaire-nacc version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional activities questionnaire-nacc version | rel=r_associated | relid=0 | w=34
  64. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:generalized anxiety disorder - 7 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:generalized anxiety disorder - 7 questionnaire | rel=r_associated | relid=0 | w=34
  65. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:healthy volunteer medical history questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:healthy volunteer medical history questionnaire | rel=r_associated | relid=0 | w=34
  66. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:instrumental activities of daily living
    n1=en:revised fibromyalgia impact questionnaire | n2=en:instrumental activities of daily living | rel=r_associated | relid=0 | w=34
  67. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:md anderson symptom inventory - spine tumor
    n1=en:revised fibromyalgia impact questionnaire | n2=en:md anderson symptom inventory - spine tumor | rel=r_associated | relid=0 | w=34
  68. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  69. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:ocular comfort index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:ocular comfort index questionnaire | rel=r_associated | relid=0 | w=34
  70. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:parkinson's disease quality of life scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:parkinson's disease quality of life scale questionnaire | rel=r_associated | relid=0 | w=34
  71. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:pediatric quality of life inventory
    n1=en:revised fibromyalgia impact questionnaire | n2=en:pediatric quality of life inventory | rel=r_associated | relid=0 | w=34
  72. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:taps tool - interviewer version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:taps tool - interviewer version | rel=r_associated | relid=0 | w=34
  73. en:revised fibromyalgia impact questionnaire -- r_associated #0: 34 / 0.791 -> en:unified parkinson's disease rating scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:unified parkinson's disease rating scale questionnaire | rel=r_associated | relid=0 | w=34
  74. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire | rel=r_associated | relid=0 | w=32
  75. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:asthma control test questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:asthma control test questionnaire | rel=r_associated | relid=0 | w=32
  76. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:center for epidemiologic studies depression scale revised
    n1=en:revised fibromyalgia impact questionnaire | n2=en:center for epidemiologic studies depression scale revised | rel=r_associated | relid=0 | w=32
  77. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:child health questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:child health questionnaire | rel=r_associated | relid=0 | w=32
  78. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:columbia-suicide severity rating scale baseline/screening version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale baseline/screening version questionnaire | rel=r_associated | relid=0 | w=32
  79. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire | rel=r_associated | relid=0 | w=32
  80. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:fact-bp questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-bp questionnaire | rel=r_associated | relid=0 | w=32
  81. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:fact-en questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-en questionnaire | rel=r_associated | relid=0 | w=32
  82. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:fact-g questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-g questionnaire | rel=r_associated | relid=0 | w=32
  83. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:fact-l questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-l questionnaire | rel=r_associated | relid=0 | w=32
  84. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:fact-m questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-m questionnaire | rel=r_associated | relid=0 | w=32
  85. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:fact/gog-ntx questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact/gog-ntx questionnaire | rel=r_associated | relid=0 | w=32
  86. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:functional activities questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional activities questionnaire | rel=r_associated | relid=0 | w=32
  87. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:functional assessment of cancer therapy-general version 4 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of cancer therapy-general version 4 questionnaire | rel=r_associated | relid=0 | w=32
  88. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:geriatric depression scale short form questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:geriatric depression scale short form questionnaire | rel=r_associated | relid=0 | w=32
  89. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:hearing handicap inventory for the elderly, screening version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hearing handicap inventory for the elderly, screening version | rel=r_associated | relid=0 | w=32
  90. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:hemophilia quality of life questionnaire parent's long version age group ii
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire parent's long version age group ii | rel=r_associated | relid=0 | w=32
  91. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:karnofsky performance status scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:karnofsky performance status scale questionnaire | rel=r_associated | relid=0 | w=32
  92. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:lymphedema and breast cancer questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:lymphedema and breast cancer questionnaire | rel=r_associated | relid=0 | w=32
  93. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:modified fatigue impact scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:modified fatigue impact scale questionnaire | rel=r_associated | relid=0 | w=32
  94. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:neck dissection impairment index
    n1=en:revised fibromyalgia impact questionnaire | n2=en:neck dissection impairment index | rel=r_associated | relid=0 | w=32
  95. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:patient health questionnaire - 9 item
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient health questionnaire - 9 item | rel=r_associated | relid=0 | w=32
  96. en:revised fibromyalgia impact questionnaire -- r_associated #0: 32 / 0.744 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire | rel=r_associated | relid=0 | w=32
  97. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:airway questionnaire 20
    n1=en:revised fibromyalgia impact questionnaire | n2=en:airway questionnaire 20 | rel=r_associated | relid=0 | w=31
  98. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire | rel=r_associated | relid=0 | w=31
  99. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:brief psychiatric rating scale a questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:brief psychiatric rating scale a questionnaire | rel=r_associated | relid=0 | w=31
  100. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:cdisc questionnaire terminology
    n1=en:revised fibromyalgia impact questionnaire | n2=en:cdisc questionnaire terminology | rel=r_associated | relid=0 | w=31
  101. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:childhood health assessment questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:childhood health assessment questionnaire | rel=r_associated | relid=0 | w=31
  102. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:columbia-suicide severity rating scale already enrolled subjects questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale already enrolled subjects questionnaire | rel=r_associated | relid=0 | w=31
  103. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire | rel=r_associated | relid=0 | w=31
  104. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:craig handicap assessment and reporting technique - short form paper version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:craig handicap assessment and reporting technique - short form paper version questionnaire | rel=r_associated | relid=0 | w=31
  105. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:dermatology life quality index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:dermatology life quality index questionnaire | rel=r_associated | relid=0 | w=31
  106. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:disability assessment for dementia questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:disability assessment for dementia questionnaire | rel=r_associated | relid=0 | w=31
  107. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:disability rating scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:disability rating scale questionnaire | rel=r_associated | relid=0 | w=31
  108. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:duke psychosocial questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:duke psychosocial questionnaire | rel=r_associated | relid=0 | w=31
  109. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:expanded prostate cancer index composite
    n1=en:revised fibromyalgia impact questionnaire | n2=en:expanded prostate cancer index composite | rel=r_associated | relid=0 | w=31
  110. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:faact questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:faact questionnaire | rel=r_associated | relid=0 | w=31
  111. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:fact-b questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-b questionnaire | rel=r_associated | relid=0 | w=31
  112. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:fact-e questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-e questionnaire | rel=r_associated | relid=0 | w=31
  113. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:fact-leu questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-leu questionnaire | rel=r_associated | relid=0 | w=31
  114. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:fact-n questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-n questionnaire | rel=r_associated | relid=0 | w=31
  115. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:functional assessment of multiple sclerosis questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of multiple sclerosis questionnaire | rel=r_associated | relid=0 | w=31
  116. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:hemophilia quality of life questionnaire children's long version age group ii
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group ii | rel=r_associated | relid=0 | w=31
  117. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:hemophilia quality of life questionnaire children's short version age group i
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire children's short version age group i | rel=r_associated | relid=0 | w=31
  118. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:hemophilia quality of life questionnaire parent's long version age group iii
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire parent's long version age group iii | rel=r_associated | relid=0 | w=31
  119. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:impact of visual impairment scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:impact of visual impairment scale questionnaire | rel=r_associated | relid=0 | w=31
  120. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:influenza intensity and impact questionnaire once daily version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:influenza intensity and impact questionnaire once daily version | rel=r_associated | relid=0 | w=31
  121. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:memorial symptom assessment scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:memorial symptom assessment scale | rel=r_associated | relid=0 | w=31
  122. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:montgomery-asberg depression rating scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:montgomery-asberg depression rating scale questionnaire | rel=r_associated | relid=0 | w=31
  123. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:neuropathic pain scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:neuropathic pain scale questionnaire | rel=r_associated | relid=0 | w=31
  124. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:osoba nausea and emesis module
    n1=en:revised fibromyalgia impact questionnaire | n2=en:osoba nausea and emesis module | rel=r_associated | relid=0 | w=31
  125. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:patient health questionnaire screener version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient health questionnaire screener version | rel=r_associated | relid=0 | w=31
  126. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:patient satisfaction questionnaire short form
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient satisfaction questionnaire short form | rel=r_associated | relid=0 | w=31
  127. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:quality of life questionnaire - testicular cancer 26
    n1=en:revised fibromyalgia impact questionnaire | n2=en:quality of life questionnaire - testicular cancer 26 | rel=r_associated | relid=0 | w=31
  128. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:short opiate withdrawal scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:short opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=31
  129. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:wechsler memory scale - fourth edition
    n1=en:revised fibromyalgia impact questionnaire | n2=en:wechsler memory scale - fourth edition | rel=r_associated | relid=0 | w=31
  130. en:revised fibromyalgia impact questionnaire -- r_associated #0: 31 / 0.721 -> en:young mania rating scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:young mania rating scale questionnaire | rel=r_associated | relid=0 | w=31
  131. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:adult hope scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:adult hope scale | rel=r_associated | relid=0 | w=30
  132. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:cdisc questionnaire category terminology
    n1=en:revised fibromyalgia impact questionnaire | n2=en:cdisc questionnaire category terminology | rel=r_associated | relid=0 | w=30
  133. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:children's dermatology life quality index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:children's dermatology life quality index questionnaire | rel=r_associated | relid=0 | w=30
  134. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:children's memory scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:children's memory scale | rel=r_associated | relid=0 | w=30
  135. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire | rel=r_associated | relid=0 | w=30
  136. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:faces pain scale revised questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:faces pain scale revised questionnaire | rel=r_associated | relid=0 | w=30
  137. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:fact-bmt questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-bmt questionnaire | rel=r_associated | relid=0 | w=30
  138. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:fact-br questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-br questionnaire | rel=r_associated | relid=0 | w=30
  139. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:fact-c questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-c questionnaire | rel=r_associated | relid=0 | w=30
  140. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:fact-th11 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-th11 questionnaire | rel=r_associated | relid=0 | w=30
  141. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:functional assessment of human immunodeficiency virus infection
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of human immunodeficiency virus infection | rel=r_associated | relid=0 | w=30
  142. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:health assessment questionnaire disability index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:health assessment questionnaire disability index questionnaire | rel=r_associated | relid=0 | w=30
  143. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:health assessment questionnaire-ii
    n1=en:revised fibromyalgia impact questionnaire | n2=en:health assessment questionnaire-ii | rel=r_associated | relid=0 | w=30
  144. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:kurtzke functional systems scores questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:kurtzke functional systems scores questionnaire | rel=r_associated | relid=0 | w=30
  145. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:list of threatening experiences questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:list of threatening experiences questionnaire | rel=r_associated | relid=0 | w=30
  146. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:md anderson symptom inventory - head and neck
    n1=en:revised fibromyalgia impact questionnaire | n2=en:md anderson symptom inventory - head and neck | rel=r_associated | relid=0 | w=30
  147. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:medical outcomes study social support survey
    n1=en:revised fibromyalgia impact questionnaire | n2=en:medical outcomes study social support survey | rel=r_associated | relid=0 | w=30
  148. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:memorial symptom assessment scale - short form
    n1=en:revised fibromyalgia impact questionnaire | n2=en:memorial symptom assessment scale - short form | rel=r_associated | relid=0 | w=30
  149. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:mini-mental status exam
    n1=en:revised fibromyalgia impact questionnaire | n2=en:mini-mental status exam | rel=r_associated | relid=0 | w=30
  150. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:modified rankin scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:modified rankin scale questionnaire | rel=r_associated | relid=0 | w=30
  151. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:outcome satisfaction questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:outcome satisfaction questionnaire | rel=r_associated | relid=0 | w=30
  152. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:promis adult sleep-related impairment item bank
    n1=en:revised fibromyalgia impact questionnaire | n2=en:promis adult sleep-related impairment item bank | rel=r_associated | relid=0 | w=30
  153. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21
    n1=en:revised fibromyalgia impact questionnaire | n2=en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 | rel=r_associated | relid=0 | w=30
  154. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:roland morris disability questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:roland morris disability questionnaire | rel=r_associated | relid=0 | w=30
  155. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:st. george's respiratory questionnaire past 3 months version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:st. george's respiratory questionnaire past 3 months version | rel=r_associated | relid=0 | w=30
  156. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:transition dyspnea index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:transition dyspnea index questionnaire | rel=r_associated | relid=0 | w=30
  157. en:revised fibromyalgia impact questionnaire -- r_associated #0: 30 / 0.698 -> en:work productivity and activity impairment general health v2.0 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:work productivity and activity impairment general health v2.0 questionnaire | rel=r_associated | relid=0 | w=30
  158. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:alzheimer's disease cooperative study-clinical global impression of change questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alzheimer's disease cooperative study-clinical global impression of change questionnaire | rel=r_associated | relid=0 | w=29
  159. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:arizona sexual experiences scale-female version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:arizona sexual experiences scale-female version questionnaire | rel=r_associated | relid=0 | w=29
  160. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:australia-modified karnofsky performance scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:australia-modified karnofsky performance scale | rel=r_associated | relid=0 | w=29
  161. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:borg category-ratio 10 scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:borg category-ratio 10 scale questionnaire | rel=r_associated | relid=0 | w=29
  162. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:borg category-ratio 10 scale score 11 point scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:borg category-ratio 10 scale score 11 point scale | rel=r_associated | relid=0 | w=29
  163. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:cancer rehabilitation evaluation system for research
    n1=en:revised fibromyalgia impact questionnaire | n2=en:cancer rehabilitation evaluation system for research | rel=r_associated | relid=0 | w=29
  164. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:columbia-suicide severity rating scale baseline questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale baseline questionnaire | rel=r_associated | relid=0 | w=29
  165. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:columbia-suicide severity rating scale children's since last visit questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale children's since last visit questionnaire | rel=r_associated | relid=0 | w=29
  166. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:eortc/rotg late radiation morbidity scoring criteria
    n1=en:revised fibromyalgia impact questionnaire | n2=en:eortc/rotg late radiation morbidity scoring criteria | rel=r_associated | relid=0 | w=29
  167. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:extended glasgow outcome scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:extended glasgow outcome scale questionnaire | rel=r_associated | relid=0 | w=29
  168. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:fact-an questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-an questionnaire | rel=r_associated | relid=0 | w=29
  169. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:fact-brm questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-brm questionnaire | rel=r_associated | relid=0 | w=29
  170. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:fact-es questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-es questionnaire | rel=r_associated | relid=0 | w=29
  171. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:fksi-15 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fksi-15 questionnaire | rel=r_associated | relid=0 | w=29
  172. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire | rel=r_associated | relid=0 | w=29
  173. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:geriatric depression scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:geriatric depression scale questionnaire | rel=r_associated | relid=0 | w=29
  174. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:hospital anxiety and depression scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hospital anxiety and depression scale questionnaire | rel=r_associated | relid=0 | w=29
  175. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:influenza intensity and impact questionnaire twice daily version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:influenza intensity and impact questionnaire twice daily version | rel=r_associated | relid=0 | w=29
  176. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:international index of erectile function questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:international index of erectile function questionnaire | rel=r_associated | relid=0 | w=29
  177. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:kurtzke expanded disability status scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:kurtzke expanded disability status scale questionnaire | rel=r_associated | relid=0 | w=29
  178. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire | rel=r_associated | relid=0 | w=29
  179. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:neuropsychiatric inventory questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:neuropsychiatric inventory questionnaire | rel=r_associated | relid=0 | w=29
  180. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:older americans resources and services comorbidity scale
    n1=en:revised fibromyalgia impact questionnaire | n2=en:older americans resources and services comorbidity scale | rel=r_associated | relid=0 | w=29
  181. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:sf-36
    n1=en:revised fibromyalgia impact questionnaire | n2=en:sf-36 | rel=r_associated | relid=0 | w=29
  182. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:st. george's respiratory questionnaire past 4 weeks version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:st. george's respiratory questionnaire past 4 weeks version | rel=r_associated | relid=0 | w=29
  183. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:standards general clinical global impressions questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:standards general clinical global impressions questionnaire | rel=r_associated | relid=0 | w=29
  184. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:ten promis global health questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:ten promis global health questionnaire | rel=r_associated | relid=0 | w=29
  185. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:the expanded prostate cancer index composite short form questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:the expanded prostate cancer index composite short form questionnaire | rel=r_associated | relid=0 | w=29
  186. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:university of washington quality of life scale, version 4
    n1=en:revised fibromyalgia impact questionnaire | n2=en:university of washington quality of life scale, version 4 | rel=r_associated | relid=0 | w=29
  187. en:revised fibromyalgia impact questionnaire -- r_associated #0: 29 / 0.674 -> en:urgency perception scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:urgency perception scale questionnaire | rel=r_associated | relid=0 | w=29
  188. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:breast cancer treatment outcomes scale-cosmetic status
    n1=en:revised fibromyalgia impact questionnaire | n2=en:breast cancer treatment outcomes scale-cosmetic status | rel=r_associated | relid=0 | w=28
  189. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:california verbal learning test - second edition
    n1=en:revised fibromyalgia impact questionnaire | n2=en:california verbal learning test - second edition | rel=r_associated | relid=0 | w=28
  190. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:cdisc sdtm terminology
    n1=en:revised fibromyalgia impact questionnaire | n2=en:cdisc sdtm terminology | rel=r_associated | relid=0 | w=28
  191. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:chronic respiratory questionnaire self-administered standardized format
    n1=en:revised fibromyalgia impact questionnaire | n2=en:chronic respiratory questionnaire self-administered standardized format | rel=r_associated | relid=0 | w=28
  192. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:clinical copd questionnaire 1 week version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:clinical copd questionnaire 1 week version | rel=r_associated | relid=0 | w=28
  193. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:columbia-suicide severity rating scale children's baseline/screening questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale children's baseline/screening questionnaire | rel=r_associated | relid=0 | w=28
  194. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:columbia-suicide severity rating scale screening questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale screening questionnaire | rel=r_associated | relid=0 | w=28
  195. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:eastern cooperative oncology group performance status questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:eastern cooperative oncology group performance status questionnaire | rel=r_associated | relid=0 | w=28
  196. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:epworth sleepiness scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:epworth sleepiness scale questionnaire | rel=r_associated | relid=0 | w=28
  197. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:european quality of life five dimension five level scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:european quality of life five dimension five level scale questionnaire | rel=r_associated | relid=0 | w=28
  198. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:expanded disability rating scale - postacute interview caregiver version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:expanded disability rating scale - postacute interview caregiver version questionnaire | rel=r_associated | relid=0 | w=28
  199. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:expanded disability rating scale - postacute interview survivor version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:expanded disability rating scale - postacute interview survivor version questionnaire | rel=r_associated | relid=0 | w=28
  200. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:fait-u questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fait-u questionnaire | rel=r_associated | relid=0 | w=28
  201. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:global rating of change in joint pain and stiffness questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:global rating of change in joint pain and stiffness questionnaire | rel=r_associated | relid=0 | w=28
  202. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:initial outcome satisfaction questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:initial outcome satisfaction questionnaire | rel=r_associated | relid=0 | w=28
  203. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:md anderson dysphagia inventory
    n1=en:revised fibromyalgia impact questionnaire | n2=en:md anderson dysphagia inventory | rel=r_associated | relid=0 | w=28
  204. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:md anderson symptom inventory - lung chemoradiation
    n1=en:revised fibromyalgia impact questionnaire | n2=en:md anderson symptom inventory - lung chemoradiation | rel=r_associated | relid=0 | w=28
  205. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:michigan neuropathy screening instrument questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:michigan neuropathy screening instrument questionnaire | rel=r_associated | relid=0 | w=28
  206. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:movement disorder society unified parkinson's disease rating scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:movement disorder society unified parkinson's disease rating scale questionnaire | rel=r_associated | relid=0 | w=28
  207. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:multinational association of supportive care in cancer antiemesis tool
    n1=en:revised fibromyalgia impact questionnaire | n2=en:multinational association of supportive care in cancer antiemesis tool | rel=r_associated | relid=0 | w=28
  208. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:multiple sclerosis impact scale version 1 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:multiple sclerosis impact scale version 1 questionnaire | rel=r_associated | relid=0 | w=28
  209. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:myeloproliferative neoplasm symptom assessment form
    n1=en:revised fibromyalgia impact questionnaire | n2=en:myeloproliferative neoplasm symptom assessment form | rel=r_associated | relid=0 | w=28
  210. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:patient health questionnaire - 15 item
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient health questionnaire - 15 item | rel=r_associated | relid=0 | w=28
  211. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:quality of life questionnaire-multiple myeloma 20
    n1=en:revised fibromyalgia impact questionnaire | n2=en:quality of life questionnaire-multiple myeloma 20 | rel=r_associated | relid=0 | w=28
  212. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:was it worth it questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:was it worth it questionnaire | rel=r_associated | relid=0 | w=28
  213. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:woodcock-johnson tests of cognitive abilities
    n1=en:revised fibromyalgia impact questionnaire | n2=en:woodcock-johnson tests of cognitive abilities | rel=r_associated | relid=0 | w=28
  214. en:revised fibromyalgia impact questionnaire -- r_associated #0: 28 / 0.651 -> en:work limitations questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:work limitations questionnaire | rel=r_associated | relid=0 | w=28
  215. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:arizona sexual experiences scale-male version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:arizona sexual experiences scale-male version questionnaire | rel=r_associated | relid=0 | w=27
  216. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:attitudes and preferences questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:attitudes and preferences questionnaire | rel=r_associated | relid=0 | w=27
  217. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:charlson comorbidity index chart review version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:charlson comorbidity index chart review version | rel=r_associated | relid=0 | w=27
  218. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:clinical dementia rating questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:clinical dementia rating questionnaire | rel=r_associated | relid=0 | w=27
  219. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:european quality of life five dimension three level questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:european quality of life five dimension three level questionnaire | rel=r_associated | relid=0 | w=27
  220. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:follow-up embodiment/outcomes questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:follow-up embodiment/outcomes questionnaire | rel=r_associated | relid=0 | w=27
  221. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:functional assessment of cancer therapy-ovarian symptom index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of cancer therapy-ovarian symptom index questionnaire | rel=r_associated | relid=0 | w=27
  222. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:generalized anxiety disorder questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:generalized anxiety disorder questionnaire | rel=r_associated | relid=0 | w=27
  223. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:health assessment questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:health assessment questionnaire | rel=r_associated | relid=0 | w=27
  224. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:mayo-portland adaptability inventory-4 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:mayo-portland adaptability inventory-4 questionnaire | rel=r_associated | relid=0 | w=27
  225. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:menstrual distress questionnaire form-t (today)
    n1=en:revised fibromyalgia impact questionnaire | n2=en:menstrual distress questionnaire form-t (today) | rel=r_associated | relid=0 | w=27
  226. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:modified hachinski ischemic scale-nacc version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:modified hachinski ischemic scale-nacc version questionnaire | rel=r_associated | relid=0 | w=27
  227. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:nurses' health study ii activity and inactivity questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:nurses' health study ii activity and inactivity questionnaire | rel=r_associated | relid=0 | w=27
  228. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:patient determined disease steps questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient determined disease steps questionnaire | rel=r_associated | relid=0 | w=27
  229. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:prognosis treatment and perceptions questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:prognosis treatment and perceptions questionnaire | rel=r_associated | relid=0 | w=27
  230. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:prostate cancer specific quality of life instrument questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:prostate cancer specific quality of life instrument questionnaire | rel=r_associated | relid=0 | w=27
  231. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:rand 36-item health survey 1.0 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:rand 36-item health survey 1.0 questionnaire | rel=r_associated | relid=0 | w=27
  232. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:visual functioning questionnaire 25-self administered format version 2000
    n1=en:revised fibromyalgia impact questionnaire | n2=en:visual functioning questionnaire 25-self administered format version 2000 | rel=r_associated | relid=0 | w=27
  233. en:revised fibromyalgia impact questionnaire -- r_associated #0: 27 / 0.628 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire | rel=r_associated | relid=0 | w=27
  234. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:6-item orientation-memory-concentration test
    n1=en:revised fibromyalgia impact questionnaire | n2=en:6-item orientation-memory-concentration test | rel=r_associated | relid=0 | w=26
  235. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:abnormal involuntary movement scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:abnormal involuntary movement scale questionnaire | rel=r_associated | relid=0 | w=26
  236. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:adhd rating scale-iv home version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:adhd rating scale-iv home version questionnaire | rel=r_associated | relid=0 | w=26
  237. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire | rel=r_associated | relid=0 | w=26
  238. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:baseline dyspnea index questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:baseline dyspnea index questionnaire | rel=r_associated | relid=0 | w=26
  239. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:bowel control scale questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:bowel control scale questionnaire | rel=r_associated | relid=0 | w=26
  240. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:breast lymphedema symptom survey
    n1=en:revised fibromyalgia impact questionnaire | n2=en:breast lymphedema symptom survey | rel=r_associated | relid=0 | w=26
  241. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:brief pain inventory short form questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:brief pain inventory short form questionnaire | rel=r_associated | relid=0 | w=26
  242. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:cancer patient tobacco use questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:cancer patient tobacco use questionnaire | rel=r_associated | relid=0 | w=26
  243. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:cdisc qrs terminology
    n1=en:revised fibromyalgia impact questionnaire | n2=en:cdisc qrs terminology | rel=r_associated | relid=0 | w=26
  244. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:clinical data interchange standards consortium terminology
    n1=en:revised fibromyalgia impact questionnaire | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=26
  245. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:clinical global impression questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:clinical global impression questionnaire | rel=r_associated | relid=0 | w=26
  246. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire | rel=r_associated | relid=0 | w=26
  247. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:craig handicap assessment and reporting technique-short form interview version questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:craig handicap assessment and reporting technique-short form interview version questionnaire | rel=r_associated | relid=0 | w=26
  248. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:disease steps questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:disease steps questionnaire | rel=r_associated | relid=0 | w=26
  249. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:european quality of life five dimension three level youth questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:european quality of life five dimension three level youth questionnaire | rel=r_associated | relid=0 | w=26
  250. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:expanded prostate cancer index composite for clinical practice questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:expanded prostate cancer index composite for clinical practice questionnaire | rel=r_associated | relid=0 | w=26
  251. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-cns questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-cns questionnaire | rel=r_associated | relid=0 | w=26
  252. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-cognitive function
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-cognitive function | rel=r_associated | relid=0 | w=26
  253. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-cx questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-cx questionnaire | rel=r_associated | relid=0 | w=26
  254. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-ga questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-ga questionnaire | rel=r_associated | relid=0 | w=26
  255. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-p questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-p questionnaire | rel=r_associated | relid=0 | w=26
  256. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-taxane questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:fact-taxane questionnaire | rel=r_associated | relid=0 | w=26
  257. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:functional assessment of cancer therapy-breast version 4 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of cancer therapy-breast version 4 questionnaire | rel=r_associated | relid=0 | w=26
  258. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:functional assessment of cancer therapy-prostate version 4 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:functional assessment of cancer therapy-prostate version 4 questionnaire | rel=r_associated | relid=0 | w=26
  259. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:hemophilia quality of life questionnaire adult version
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire adult version | rel=r_associated | relid=0 | w=26
  260. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:hemophilia quality of life questionnaire children's long version age group i
    n1=en:revised fibromyalgia impact questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group i | rel=r_associated | relid=0 | w=26
  261. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:md anderson symptom inventory - brain tumor
    n1=en:revised fibromyalgia impact questionnaire | n2=en:md anderson symptom inventory - brain tumor | rel=r_associated | relid=0 | w=26
  262. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:md anderson symptom inventory - core
    n1=en:revised fibromyalgia impact questionnaire | n2=en:md anderson symptom inventory - core | rel=r_associated | relid=0 | w=26
  263. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:medical outcomes study your feelings questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:medical outcomes study your feelings questionnaire | rel=r_associated | relid=0 | w=26
  264. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:modified barium swallow impairment profile
    n1=en:revised fibromyalgia impact questionnaire | n2=en:modified barium swallow impairment profile | rel=r_associated | relid=0 | w=26
  265. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire | rel=r_associated | relid=0 | w=26
  266. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:patient health questionnaire-2
    n1=en:revised fibromyalgia impact questionnaire | n2=en:patient health questionnaire-2 | rel=r_associated | relid=0 | w=26
  267. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:primary care evaluation of mental disorders patient health questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:primary care evaluation of mental disorders patient health questionnaire | rel=r_associated | relid=0 | w=26
  268. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:rcc symptom index
    n1=en:revised fibromyalgia impact questionnaire | n2=en:rcc symptom index | rel=r_associated | relid=0 | w=26
  269. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:screener and opioid assessment for patients with pain revised questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:screener and opioid assessment for patients with pain revised questionnaire | rel=r_associated | relid=0 | w=26
  270. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients
    n1=en:revised fibromyalgia impact questionnaire | n2=en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients | rel=r_associated | relid=0 | w=26
  271. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:standards pain intensity questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:standards pain intensity questionnaire | rel=r_associated | relid=0 | w=26
  272. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:the oswestry disability index version 2.1a questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:the oswestry disability index version 2.1a questionnaire | rel=r_associated | relid=0 | w=26
  273. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:visual functioning questionnaire 25-interviewer administered format version 2000
    n1=en:revised fibromyalgia impact questionnaire | n2=en:visual functioning questionnaire 25-interviewer administered format version 2000 | rel=r_associated | relid=0 | w=26
  274. en:revised fibromyalgia impact questionnaire -- r_associated #0: 26 / 0.605 -> en:work productivity and activity impairment specific health problems version 2.0 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:work productivity and activity impairment specific health problems version 2.0 questionnaire | rel=r_associated | relid=0 | w=26
  275. en:revised fibromyalgia impact questionnaire -- r_associated #0: 20 / 0.465 -> en:aya-hears
    n1=en:revised fibromyalgia impact questionnaire | n2=en:aya-hears | rel=r_associated | relid=0 | w=20
  276. en:revised fibromyalgia impact questionnaire -- r_associated #0: 20 / 0.465 -> en:brief psychiatric rating scale - version 4
    n1=en:revised fibromyalgia impact questionnaire | n2=en:brief psychiatric rating scale - version 4 | rel=r_associated | relid=0 | w=20
  277. en:revised fibromyalgia impact questionnaire -- r_associated #0: 1 / 0.023 -> en:intellectual product
    n1=en:revised fibromyalgia impact questionnaire | n2=en:intellectual product | rel=r_associated | relid=0 | w=1
≈ 276 relations entrantes

  1. en:functional assessment of cancer therapy-breast version 4 questionnaire --- r_associated #0: 38 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of cancer therapy-breast version 4 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=38
  2. en:bladder control scale questionnaire --- r_associated #0: 35 --> en:revised fibromyalgia impact questionnaire
    n1=en:bladder control scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=35
  3. en:brief pain inventory short form questionnaire --- r_associated #0: 35 --> en:revised fibromyalgia impact questionnaire
    n1=en:brief pain inventory short form questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=35
  4. en:fksi-15 questionnaire --- r_associated #0: 35 --> en:revised fibromyalgia impact questionnaire
    n1=en:fksi-15 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=35
  5. en:hemophilia quality of life questionnaire children's long version age group ii --- r_associated #0: 35 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire children's long version age group ii | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=35
  6. en:st. george's respiratory questionnaire past 3 months version --- r_associated #0: 35 --> en:revised fibromyalgia impact questionnaire
    n1=en:st. george's respiratory questionnaire past 3 months version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=35
  7. en:human activity profile --- r_associated #0: 34 --> en:revised fibromyalgia impact questionnaire
    n1=en:human activity profile | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=34
  8. en:instrumental activities of daily living --- r_associated #0: 34 --> en:revised fibromyalgia impact questionnaire
    n1=en:instrumental activities of daily living | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=34
  9. en:university of washington quality of life scale, version 4 --- r_associated #0: 34 --> en:revised fibromyalgia impact questionnaire
    n1=en:university of washington quality of life scale, version 4 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=34
  10. en:fact-b questionnaire --- r_associated #0: 32 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-b questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=32
  11. en:md anderson symptom inventory - core --- r_associated #0: 32 --> en:revised fibromyalgia impact questionnaire
    n1=en:md anderson symptom inventory - core | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=32
  12. en:modified barium swallow impairment profile --- r_associated #0: 32 --> en:revised fibromyalgia impact questionnaire
    n1=en:modified barium swallow impairment profile | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=32
  13. en:work productivity and activity impairment general health v2.0 questionnaire --- r_associated #0: 32 --> en:revised fibromyalgia impact questionnaire
    n1=en:work productivity and activity impairment general health v2.0 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=32
  14. en:adult hope scale --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:adult hope scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  15. en:breast cancer treatment outcomes scale-cosmetic status --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:breast cancer treatment outcomes scale-cosmetic status | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  16. en:child health questionnaire --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:child health questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  17. en:clinical dementia rating questionnaire --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:clinical dementia rating questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  18. en:columbia-suicide severity rating scale baseline/screening version questionnaire --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale baseline/screening version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  19. en:eortc/rotg late radiation morbidity scoring criteria --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:eortc/rotg late radiation morbidity scoring criteria | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  20. en:hearing handicap inventory for the elderly, screening version --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:hearing handicap inventory for the elderly, screening version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  21. en:taps tool - interviewer version --- r_associated #0: 31 --> en:revised fibromyalgia impact questionnaire
    n1=en:taps tool - interviewer version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=31
  22. en:bowel control scale questionnaire --- r_associated #0: 30 --> en:revised fibromyalgia impact questionnaire
    n1=en:bowel control scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=30
  23. en:extended glasgow outcome scale questionnaire --- r_associated #0: 30 --> en:revised fibromyalgia impact questionnaire
    n1=en:extended glasgow outcome scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=30
  24. en:impact of visual impairment scale questionnaire --- r_associated #0: 30 --> en:revised fibromyalgia impact questionnaire
    n1=en:impact of visual impairment scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=30
  25. en:alcohol use disorder identification test self-report version questionnaire --- r_associated #0: 29 --> en:revised fibromyalgia impact questionnaire
    n1=en:alcohol use disorder identification test self-report version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=29
  26. en:brief psychiatric rating scale - version 4 --- r_associated #0: 29 --> en:revised fibromyalgia impact questionnaire
    n1=en:brief psychiatric rating scale - version 4 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=29
  27. en:cdisc qrs terminology --- r_associated #0: 29 --> en:revised fibromyalgia impact questionnaire
    n1=en:cdisc qrs terminology | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=29
  28. en:center for epidemiologic studies depression scale revised --- r_associated #0: 29 --> en:revised fibromyalgia impact questionnaire
    n1=en:center for epidemiologic studies depression scale revised | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=29
  29. en:subjective numeracy scale --- r_associated #0: 29 --> en:revised fibromyalgia impact questionnaire
    n1=en:subjective numeracy scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=29
  30. en:woodcock-johnson tests of cognitive abilities --- r_associated #0: 29 --> en:revised fibromyalgia impact questionnaire
    n1=en:woodcock-johnson tests of cognitive abilities | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=29
  31. en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 --- r_associated #0: 28 --> en:revised fibromyalgia impact questionnaire
    n1=en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=28
  32. en:shortness of breath with daily activities questionnaire --- r_associated #0: 28 --> en:revised fibromyalgia impact questionnaire
    n1=en:shortness of breath with daily activities questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=28
  33. en:wechsler memory scale - fourth edition --- r_associated #0: 28 --> en:revised fibromyalgia impact questionnaire
    n1=en:wechsler memory scale - fourth edition | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=28
  34. en:alzheimer's disease cooperative study-clinical global impression of change questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:alzheimer's disease cooperative study-clinical global impression of change questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  35. en:borg scale rating of perceived exertion questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:borg scale rating of perceived exertion questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  36. en:cdisc questionnaire terminology --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:cdisc questionnaire terminology | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  37. en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  38. en:fact-n questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-n questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  39. en:functional assessment of cancer therapy-ovarian symptom index questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of cancer therapy-ovarian symptom index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  40. en:smoking self-efficacy questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:smoking self-efficacy questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  41. en:the expanded prostate cancer index composite short form questionnaire --- r_associated #0: 27 --> en:revised fibromyalgia impact questionnaire
    n1=en:the expanded prostate cancer index composite short form questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=27
  42. en:aya-hears --- r_associated #0: 26 --> en:revised fibromyalgia impact questionnaire
    n1=en:aya-hears | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26
  43. en:clinical global impression questionnaire --- r_associated #0: 26 --> en:revised fibromyalgia impact questionnaire
    n1=en:clinical global impression questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26
  44. en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire --- r_associated #0: 26 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26
  45. en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire --- r_associated #0: 26 --> en:revised fibromyalgia impact questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26
  46. en:satisfaction with life scale questionnaire --- r_associated #0: 26 --> en:revised fibromyalgia impact questionnaire
    n1=en:satisfaction with life scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26
  47. en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire --- r_associated #0: 26 --> en:revised fibromyalgia impact questionnaire
    n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26
  48. en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire --- r_associated #0: 21 --> en:revised fibromyalgia impact questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=21
  49. en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire --- r_associated #0: 21 --> en:revised fibromyalgia impact questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=21
  50. en:12-item multiple sclerosis walking scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:12-item multiple sclerosis walking scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  51. en:6-item orientation-memory-concentration test --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:6-item orientation-memory-concentration test | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  52. en:abnormal involuntary movement scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:abnormal involuntary movement scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  53. en:activities of daily living dimension of functioning questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:activities of daily living dimension of functioning questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  54. en:adhd rating scale-iv home version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:adhd rating scale-iv home version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  55. en:airway questionnaire 20 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:airway questionnaire 20 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  56. en:alcohol use disorder identification test alcohol consumption questions questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:alcohol use disorder identification test alcohol consumption questions questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  57. en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  58. en:alzheimer's disease cooperative study activities of daily living inventory questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:alzheimer's disease cooperative study activities of daily living inventory questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  59. en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  60. en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  61. en:arizona sexual experiences scale-female version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:arizona sexual experiences scale-female version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  62. en:arizona sexual experiences scale-male version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:arizona sexual experiences scale-male version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  63. en:assessment of survivor concerns --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:assessment of survivor concerns | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  64. en:asthma control questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:asthma control questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  65. en:asthma control test questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:asthma control test questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  66. en:asthma quality of life questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:asthma quality of life questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  67. en:attitudes and preferences questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:attitudes and preferences questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  68. en:australia-modified karnofsky performance scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:australia-modified karnofsky performance scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  69. en:barnes akathisia rating scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:barnes akathisia rating scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  70. en:baseline dyspnea index questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:baseline dyspnea index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  71. en:borg category-ratio 10 scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:borg category-ratio 10 scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  72. en:borg category-ratio 10 scale score 11 point scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:borg category-ratio 10 scale score 11 point scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  73. en:breast cancer prevention trial symptom scales --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:breast cancer prevention trial symptom scales | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  74. en:breast lymphedema symptom survey --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:breast lymphedema symptom survey | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  75. en:brief pain inventory questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:brief pain inventory questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  76. en:brief psychiatric rating scale a questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:brief psychiatric rating scale a questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  77. en:california verbal learning test - second edition --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:california verbal learning test - second edition | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  78. en:cancer patient tobacco use questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:cancer patient tobacco use questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  79. en:cancer rehabilitation evaluation system for research --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:cancer rehabilitation evaluation system for research | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  80. en:cdisc questionnaire category terminology --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:cdisc questionnaire category terminology | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  81. en:cdisc sdtm terminology --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:cdisc sdtm terminology | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  82. en:charlson comorbidity index chart review version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:charlson comorbidity index chart review version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  83. en:childhood health assessment questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:childhood health assessment questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  84. en:children's dermatology life quality index questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:children's dermatology life quality index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  85. en:children's memory scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:children's memory scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  86. en:chronic respiratory questionnaire self-administered standardized format --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:chronic respiratory questionnaire self-administered standardized format | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  87. en:clinical copd questionnaire 1 week version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:clinical copd questionnaire 1 week version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  88. en:clinical copd questionnaire 24 hour version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:clinical copd questionnaire 24 hour version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  89. en:clinical data interchange standards consortium terminology --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:clinical data interchange standards consortium terminology | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  90. en:clinical opiate withdrawal scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:clinical opiate withdrawal scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  91. en:columbia-suicide severity rating scale already enrolled subjects questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale already enrolled subjects questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  92. en:columbia-suicide severity rating scale baseline questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale baseline questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  93. en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  94. en:columbia-suicide severity rating scale children's baseline questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale children's baseline questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  95. en:columbia-suicide severity rating scale children's baseline/screening questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale children's baseline/screening questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  96. en:columbia-suicide severity rating scale children's since last visit questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale children's since last visit questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  97. en:columbia-suicide severity rating scale lifetime/recent version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale lifetime/recent version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  98. en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  99. en:columbia-suicide severity rating scale screening questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale screening questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  100. en:columbia-suicide severity rating scale since last visit questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:columbia-suicide severity rating scale since last visit questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  101. en:contemplation ladder for smoking cessation --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:contemplation ladder for smoking cessation | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  102. en:copd assessment test questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:copd assessment test questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  103. en:craig handicap assessment and reporting technique - short form paper version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:craig handicap assessment and reporting technique - short form paper version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  104. en:craig handicap assessment and reporting technique-short form interview version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:craig handicap assessment and reporting technique-short form interview version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  105. en:current opioid misuse measure questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:current opioid misuse measure questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  106. en:dermatology life quality index questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:dermatology life quality index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  107. en:disability assessment for dementia questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:disability assessment for dementia questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  108. en:disability rating scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:disability rating scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  109. en:disease steps questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:disease steps questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  110. en:duke psychosocial questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:duke psychosocial questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  111. en:eastern cooperative oncology group performance status questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:eastern cooperative oncology group performance status questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  112. en:epworth sleepiness scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:epworth sleepiness scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  113. en:european organization for research and treatment of cancer quality of life questionnaire core 30 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:european organization for research and treatment of cancer quality of life questionnaire core 30 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  114. en:european quality of life five dimension five level scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:european quality of life five dimension five level scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  115. en:european quality of life five dimension three level questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:european quality of life five dimension three level questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  116. en:european quality of life five dimension three level youth questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:european quality of life five dimension three level youth questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  117. en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  118. en:expanded disability rating scale - postacute interview caregiver version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:expanded disability rating scale - postacute interview caregiver version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  119. en:expanded disability rating scale - postacute interview survivor version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:expanded disability rating scale - postacute interview survivor version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  120. en:expanded prostate cancer index composite --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:expanded prostate cancer index composite | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  121. en:expanded prostate cancer index composite for clinical practice questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:expanded prostate cancer index composite for clinical practice questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  122. en:expanded prostate cancer index composite, sexual medications/devices supplement --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:expanded prostate cancer index composite, sexual medications/devices supplement | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  123. en:faact questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:faact questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  124. en:faces pain scale revised questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:faces pain scale revised questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  125. en:fact-an questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-an questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  126. en:fact-b+4 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-b+4 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  127. en:fact-bl questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-bl questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  128. en:fact-bmt questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-bmt questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  129. en:fact-bp questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-bp questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  130. en:fact-br questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-br questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  131. en:fact-brm questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-brm questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  132. en:fact-c questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-c questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  133. en:fact-cns questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-cns questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  134. en:fact-cognitive function --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-cognitive function | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  135. en:fact-cx questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-cx questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  136. en:fact-e questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-e questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  137. en:fact-en questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-en questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  138. en:fact-es questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-es questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  139. en:fact-g questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-g questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  140. en:fact-ga questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-ga questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  141. en:fact-hep questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-hep questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  142. en:fact-l questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-l questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  143. en:fact-leu questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-leu questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  144. en:fact-m questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-m questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  145. en:fact-mm questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-mm questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  146. en:fact-np questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-np questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  147. en:fact-o questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-o questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  148. en:fact-p questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-p questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  149. en:fact-taxane questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-taxane questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  150. en:fact-th11 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact-th11 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  151. en:fact/gog-ntx questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fact/gog-ntx questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  152. en:fait-u questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:fait-u questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  153. en:follow-up embodiment/outcomes questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:follow-up embodiment/outcomes questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  154. en:follow-up outcome expectations questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:follow-up outcome expectations questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  155. en:functional activities questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional activities questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  156. en:functional activities questionnaire-nacc version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional activities questionnaire-nacc version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  157. en:functional assessment of cancer therapy-general version 4 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of cancer therapy-general version 4 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  158. en:functional assessment of cancer therapy-prostate version 4 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of cancer therapy-prostate version 4 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  159. en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  160. en:functional assessment of human immunodeficiency virus infection --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of human immunodeficiency virus infection | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  161. en:functional assessment of multiple sclerosis questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:functional assessment of multiple sclerosis questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  162. en:generalized anxiety disorder - 7 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:generalized anxiety disorder - 7 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  163. en:generalized anxiety disorder questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:generalized anxiety disorder questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  164. en:geriatric depression scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:geriatric depression scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  165. en:geriatric depression scale short form questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:geriatric depression scale short form questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  166. en:global rating of change in joint pain and stiffness questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:global rating of change in joint pain and stiffness questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  167. en:health assessment questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:health assessment questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  168. en:health assessment questionnaire disability index questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:health assessment questionnaire disability index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  169. en:health assessment questionnaire-ii --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:health assessment questionnaire-ii | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  170. en:healthy volunteer medical history questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:healthy volunteer medical history questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  171. en:hemophilia quality of life questionnaire adult version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire adult version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  172. en:hemophilia quality of life questionnaire children's long version age group i --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire children's long version age group i | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  173. en:hemophilia quality of life questionnaire children's long version age group iii --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire children's long version age group iii | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  174. en:hemophilia quality of life questionnaire children's short version age group i --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire children's short version age group i | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  175. en:hemophilia quality of life questionnaire children's short version age group ii/iii --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire children's short version age group ii/iii | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  176. en:hemophilia quality of life questionnaire parent's long version age group i --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire parent's long version age group i | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  177. en:hemophilia quality of life questionnaire parent's long version age group ii --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire parent's long version age group ii | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  178. en:hemophilia quality of life questionnaire parent's long version age group iii --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hemophilia quality of life questionnaire parent's long version age group iii | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  179. en:hospital anxiety and depression scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:hospital anxiety and depression scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  180. en:influenza intensity and impact questionnaire once daily version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:influenza intensity and impact questionnaire once daily version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  181. en:influenza intensity and impact questionnaire twice daily version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:influenza intensity and impact questionnaire twice daily version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  182. en:initial outcome satisfaction questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:initial outcome satisfaction questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  183. en:international index of erectile function questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:international index of erectile function questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  184. en:karnofsky performance status scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:karnofsky performance status scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  185. en:kaufman assessment battery for children --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:kaufman assessment battery for children | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  186. en:kurtzke expanded disability status scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:kurtzke expanded disability status scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  187. en:kurtzke functional systems scores questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:kurtzke functional systems scores questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  188. en:list of threatening experiences questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:list of threatening experiences questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  189. en:lymphedema and breast cancer questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:lymphedema and breast cancer questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  190. en:mayo-portland adaptability inventory-4 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:mayo-portland adaptability inventory-4 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  191. en:md anderson dysphagia inventory --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:md anderson dysphagia inventory | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  192. en:md anderson symptom inventory - brain tumor --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:md anderson symptom inventory - brain tumor | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  193. en:md anderson symptom inventory - head and neck --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:md anderson symptom inventory - head and neck | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  194. en:md anderson symptom inventory - lung chemoradiation --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:md anderson symptom inventory - lung chemoradiation | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  195. en:md anderson symptom inventory - spine tumor --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:md anderson symptom inventory - spine tumor | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  196. en:medical outcomes study physical functioning scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:medical outcomes study physical functioning scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  197. en:medical outcomes study social activities --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:medical outcomes study social activities | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  198. en:medical outcomes study social support survey --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:medical outcomes study social support survey | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  199. en:medical outcomes study your feelings questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:medical outcomes study your feelings questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  200. en:memorial symptom assessment scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:memorial symptom assessment scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  201. en:memorial symptom assessment scale - short form --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:memorial symptom assessment scale - short form | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  202. en:menstrual distress questionnaire form-t (today) --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:menstrual distress questionnaire form-t (today) | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  203. en:michigan neuropathy screening instrument questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:michigan neuropathy screening instrument questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  204. en:mini-mental status exam --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:mini-mental status exam | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  205. en:modified fatigue impact scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:modified fatigue impact scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  206. en:modified hachinski ischemic scale-nacc version questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:modified hachinski ischemic scale-nacc version questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  207. en:modified medical research council dyspnea scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:modified medical research council dyspnea scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  208. en:modified rankin scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:modified rankin scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  209. en:montgomery-asberg depression rating scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:montgomery-asberg depression rating scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  210. en:movement disorder society unified parkinson's disease rating scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:movement disorder society unified parkinson's disease rating scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  211. en:multidimensional body-self relations questionnaire appearance orientation --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:multidimensional body-self relations questionnaire appearance orientation | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  212. en:multinational association of supportive care in cancer antiemesis tool --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:multinational association of supportive care in cancer antiemesis tool | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  213. en:multiple sclerosis impact scale version 1 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:multiple sclerosis impact scale version 1 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  214. en:multiple sclerosis impact scale version 2 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  215. en:multiple sclerosis quality of life-54 instrument questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:multiple sclerosis quality of life-54 instrument questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  216. en:myeloproliferative neoplasm symptom assessment form --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:myeloproliferative neoplasm symptom assessment form | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  217. en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  218. en:neck dissection impairment index --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:neck dissection impairment index | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  219. en:neuropathic pain scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:neuropathic pain scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  220. en:neuropsychiatric inventory questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:neuropsychiatric inventory questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  221. en:nurses' health study ii activity and inactivity questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:nurses' health study ii activity and inactivity questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  222. en:ocular comfort index questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:ocular comfort index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  223. en:older americans resource scale multidimensional functional assessment questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:older americans resource scale multidimensional functional assessment questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  224. en:older americans resources and services comorbidity scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:older americans resources and services comorbidity scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  225. en:osoba nausea and emesis module --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:osoba nausea and emesis module | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  226. en:outcome satisfaction questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:outcome satisfaction questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  227. en:parkinson's disease quality of life scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:parkinson's disease quality of life scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  228. en:patient determined disease steps questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient determined disease steps questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  229. en:patient health questionnaire - 15 item --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient health questionnaire - 15 item | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  230. en:patient health questionnaire - 9 item --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient health questionnaire - 9 item | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  231. en:patient health questionnaire screener version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient health questionnaire screener version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  232. en:patient health questionnaire-2 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient health questionnaire-2 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  233. en:patient reported outcomes version of ctcae --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient reported outcomes version of ctcae | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  234. en:patient satisfaction questionnaire short form --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:patient satisfaction questionnaire short form | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  235. en:pediatric quality of life inventory --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:pediatric quality of life inventory | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  236. en:perceived stress scale --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:perceived stress scale | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  237. en:primary care evaluation of mental disorders patient health questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:primary care evaluation of mental disorders patient health questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  238. en:prognosis treatment and perceptions questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:prognosis treatment and perceptions questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  239. en:promis adult sleep-related impairment item bank --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:promis adult sleep-related impairment item bank | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  240. en:prostate cancer specific quality of life instrument questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:prostate cancer specific quality of life instrument questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  241. en:quality of life questionnaire - testicular cancer 26 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:quality of life questionnaire - testicular cancer 26 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  242. en:quality of life questionnaire-multiple myeloma 20 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:quality of life questionnaire-multiple myeloma 20 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  243. en:rand 36-item health survey 1.0 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:rand 36-item health survey 1.0 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  244. en:raven's progressive matrices --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:raven's progressive matrices | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  245. en:rcc symptom index --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:rcc symptom index | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  246. en:rivermead post-concussion symptoms questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:rivermead post-concussion symptoms questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  247. en:roland morris disability questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:roland morris disability questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  248. en:screener and opioid assessment for patients with pain revised questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:screener and opioid assessment for patients with pain revised questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  249. en:sf-12 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:sf-12 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  250. en:sf-36 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:sf-36 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  251. en:sheehan disability scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:sheehan disability scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  252. en:short opiate withdrawal scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:short opiate withdrawal scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  253. en:short-form mcgill pain questionnaire-2 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:short-form mcgill pain questionnaire-2 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  254. en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  255. en:st. george's respiratory questionnaire past 4 weeks version --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:st. george's respiratory questionnaire past 4 weeks version | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  256. en:standards general clinical global impressions questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:standards general clinical global impressions questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  257. en:standards pain intensity questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:standards pain intensity questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  258. en:standards pain relief questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:standards pain relief questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  259. en:subjective opiate withdrawal scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:subjective opiate withdrawal scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  260. en:symptom impact questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:symptom impact questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  261. en:ten promis global health questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:ten promis global health questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  262. en:the oswestry disability index version 2.1a questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:the oswestry disability index version 2.1a questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  263. en:the overactive bladder questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:the overactive bladder questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  264. en:the overactive bladder questionnaire short form --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:the overactive bladder questionnaire short form | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  265. en:transition dyspnea index questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:transition dyspnea index questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  266. en:treatment satisfaction questionnaire for medication --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:treatment satisfaction questionnaire for medication | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  267. en:unified parkinson's disease rating scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:unified parkinson's disease rating scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  268. en:urgency perception scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:urgency perception scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  269. en:visual functioning questionnaire 25-interviewer administered format version 2000 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:visual functioning questionnaire 25-interviewer administered format version 2000 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  270. en:visual functioning questionnaire 25-self administered format version 2000 --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:visual functioning questionnaire 25-self administered format version 2000 | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  271. en:was it worth it questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:was it worth it questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  272. en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  273. en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  274. en:work limitations questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:work limitations questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  275. en:work productivity and activity impairment specific health problems version 2.0 questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:work productivity and activity impairment specific health problems version 2.0 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  276. en:young mania rating scale questionnaire --- r_associated #0: 20 --> en:revised fibromyalgia impact questionnaire
    n1=en:young mania rating scale questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr